Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Tevimbra 100 mg/10 ml Infusion {equilateral_black_triangle}

Active Ingredient:
Tislelizumab
Company:  
BeOne Medicines UK, Ltd. See contact details
ATC code: 
L01FF09
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Tevimbra Patient card

This Patient Card is a condition of the marketing authorisation for Tevimbra (tislelizumab) and contains important safety information that you need to be aware of. This Patient Card was developed in June 2026.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

BeOne Medicines UK, Ltd.
Company image
Address
c/o Regus London Paddington, 2 Kingdom Street, London, W2 6BD, UK
WWW
https://www.beonemed.com/
Telephone
0800 917 6799
Medical Information Direct Line
0800 4320266
Medical Information e-mail
[email protected]
Stock Availability
[email protected]
Stock Availability
0800 917 6799